In the article entitled “Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma” published in Surgical Neurology International[ there are the following figure legend corrections:Figure 3 legend is incorrectly written as Kaplan-Meier curves for overall survival in the intraoperative balloon electronic brachytherapy group stratified according to postoperative residual contrast-enhanced volume (PCEV): the subgroup of subjects with PCEV >2.5 cm3 marked in red, the subgroup of subjects with PCEV ≤2.5 cm3 marked in green; log rank χ2 = 8.03, P = 0.005, P < 0.05 instead of Kaplan-Meier curves for overall survival in the intraoperative balloon electronic brachytherapy group stratified according to postoperative residual contrast-enhanced volume (PCEV): the subgroup of subjects with PCEV >2.5 cm3 marked in green, the subgroup of subjects with PCEV ≤2.5 cm3 marked in red; log rank c2 = 8.03, P = 0.005, P < 0.05.Figure 4 legend is incorrectly written as Kaplan-Meier curves for overall survival: The intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red; Log Rank c2 = 4.23, P = 0.04, P < 0.05 instead of Kaplan-Meier curves for overall survival: The intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green; Log Rank c2 = 4.23, P = 0.04, P < 0.05.Figure 5 legend is incorrectly written as Kaplan-Meier curves for local progression-free survival: the intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red, Log Rank c2 = 4.93, P = 0.026, P < 0.05 instead of Kaplan-Meier curves for local progression-free survival: the intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green, Log Rank c2 = 4.93, P = 0.026, P < 0.05.Figure 6 legend is incorrectly written as Kaplan-Meier curves for overall survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red; Log Rank c2 = 4.13, P = 0.042, P < 0.05 instead of Kaplan-Meier curves for overall survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green; Log Rank c2 = 4.13, P = 0.042, P < 0.05.Figure 7 legend is incorrectly written as Kaplan-Meier curves for local progression-free survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in green, the control group marked in red; Log Rank c2 = 7.24, P = 0.007, P < 0.05 instead of Kaplan-Meier curves for local progression-free survival in the subgroups of subjects with postoperative residual contrast-enhanced volume ≤2.5 cm3: the intraoperative balloon electronic brachytherapy group marked in red, the control group marked in green; Log Rank c2 = 7.24, P = 0.007, P < 0.05.In Tables 3 and 5 Current status is incorrectly written as October 2020 instead of March 2021.